Comparative Activities of Daptomycin, Linezolid, and Tigecycline against Catheter-Related Methicillin-Resistant Staphylococcus Bacteremic Isolates Embedded in Biofilm
Top Cited Papers
Open Access
- 1 May 2007
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 51 (5) , 1656-1660
- https://doi.org/10.1128/aac.00350-06
Abstract
In the setting of catheter-related bloodstream infections, intraluminal antibiotic lock therapy could be useful for the salvage of vascular catheters. In this in vitro study, we investigated the efficacies of the newer antibiotics daptomycin, linezolid, and tigecycline, in comparison with those of vancomycin, minocycline, and rifampin, against methicillin-resistant Staphylococcus aureus (MRSA) embedded in biofilm. We also assessed the emergence of MRSA strains resistant to these antibiotics, alone or in combination with rifampin, after 4-hour daily use for catheter lock therapy. Minocycline, daptomycin, and tigecycline were more efficacious in inhibiting MRSA in biofilm than linezolid, vancomycin, and the negative control (P < 0.001) after the first day of exposure to these antibiotics, with minocycline being the most active, followed by daptomycin and then tigecycline, and with vancomycin and linezolid lacking activity, similar to the negative control. After 3 days of 4-hour daily exposures, daptomycin was the fastest in eradicating MRSA from biofilm, followed by minocycline and tigecycline, which were faster than linezolid, rifampin, and vancomycin (P < 0.001). When rifampin was used alone, it was the least effective in eradicating MRSA from biofilm after 5 days of 4-hour daily exposures, as it was associated with the emergence of rifampin-resistant MRSA. However, when rifampin was used in combination with other antibiotics, the combination was significantly effective in eliminating MRSA colonization in biofilm more rapidly than each of the antibiotics alone. In summary, daptomycin, minocycline, and tigecycline should be considered further for antibiotic lock therapy, and rifampin should be considered for enhanced antistaphylococcal activity but not as a single agent.Keywords
This publication has 25 references indexed in Scilit:
- Multiple Combination Bactericidal Testing of Staphylococcal Biofilms from Implant-Associated InfectionsAntimicrobial Agents and Chemotherapy, 2006
- Heparin Stimulates Staphylococcus aureus Biofilm FormationInfection and Immunity, 2005
- A Randomized, Controlled Trial of a New Vascular Catheter Flush Solution (Minocycline-EDTA) in Temporary Hemodialysis AccessInfection Control & Hospital Epidemiology, 2005
- Antibacterial activity of linezolid and vancomycin in an in vitro pharmacodynamic model of Gram-positive catheter-related bacteraemiaJournal of Antimicrobial Chemotherapy, 2005
- In Vitro Exposure of Bacteria to Antimicrobial Impregnated-Central Venous Catheters Does Not Directly Lead to the Emergence of Antimicrobial ResistanceChest, 2004
- Venous Access Port–Related Bacteremia in Patients with Acquired Immunodeficiency Syndrome or Cancer: The Reservoir as a Diagnostic and Therapeutic ToolClinical Infectious Diseases, 2001
- In vitro evaluation of the risk of developing bacterial resistance to antiseptics and antibiotics used in medical devicesJournal of Antimicrobial Chemotherapy, 2001
- Guidelines for the Management of Intravascular Catheter-Related InfectionsClinical Infectious Diseases, 2001
- Central Venous Catheters Coated with Minocycline and Rifampin for the Prevention of Catheter-Related Colonization and Bloodstream InfectionsAnnals of Internal Medicine, 1997
- Antibiotics and prevention of microbial colonization of cathetersAntimicrobial Agents and Chemotherapy, 1995